Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Diprotin A

DPP4 inhibitor
 
ALX-260-036-M005 5 mg 46.00 USD
 
ALX-260-036-M025 25 mg 75.00 USD
Do you need bulk/larger quantities?
 
Inhibitor of dipeptidyl aminopeptidase IV.

Product Specification

Alternative Name:H-Ile-Pro-Ile-OH
 
Formula:C17H31N3O4
 
MW:341.5
 
Source:Synthetic.
 
CAS:90614-48-5
 
Purity:≥98% (HPLC)
 
Appearance:White to off-white solid.
 
Application Notes:May be used to inhibit GLP-1 breakdown in blood, plasma and serum samples at a concentration of 100 µM.
 
Solubility:Soluble in water (1mg/ml).
 
Shipping:Ambient
 
Long Term Storage:-20°C
 

Product Literature References

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig: C.F. Deacon, et al.; Diabetes 47, 764 (1998), Abstract; Full Text
Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum: R. Mentlein, et al.; Eur. J. Biochem. 214, 829 (1993), Abstract; Full Text
Murine thymocytes possess specific cell surface-associated exoaminopeptidase activities: preferential expression by immature CD4- CD8- subpopulation: B. Bauvois; Eur. J. Immunol. 20, 459 (1990), Abstract;
Purification and some properties of a membrane-bound dipeptidyl peptidase IV of guinea pig casein-induced intraperitoneal leukocytes: M. Kudo, et al.; J. Biochem. 97, 1211 (1985), Abstract;
Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria: H. Umezawa, et al.; J. Antibiot. 37, 422 (1984), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
DPP
By biological activity:
DPP Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,